Cite

HARVARD Citation

    Herbert, K. et al. (2018). T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics. Cell death and disease. 9 (11), pp. 1-10. [Online]. 
  
Back to record